Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
Phase 2 Study of Bexxar in Relapsed/Refractory DLCL
ClinicalTrials.gov study NCT00490009. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
ClinicalTrials.gov study NCT05066672. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome
ClinicalTrials.gov study NCT05126563. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years
ClinicalTrials.gov study NCT02269488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
ClinicalTrials.gov study NCT04849988. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
ClinicalTrials.gov study NCT02348918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01466153. IPD Sharing: Not stated. Countries: 8. Publications: 0.
A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT07123090. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
ClinicalTrials.gov study NCT02498613. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
ClinicalTrials.gov study NCT03987295. IPD Sharing: NO. Countries: 6. Publications: 0.
Screening Wizard- Phase 2
ClinicalTrials.gov study NCT04646369. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
ClinicalTrials.gov study NCT07073638. IPD Sharing: NO. Countries: 1. Publications: 0.
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00380588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas
ClinicalTrials.gov study NCT03808558. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT01855828. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
ClinicalTrials.gov study NCT06655896. IPD Sharing: YES. Countries: 18. Publications: 0.
A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
ClinicalTrials.gov study NCT06805617. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label
ClinicalTrials.gov study NCT02318368. IPD Sharing: NO. Countries: 7. Publications: 0.
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
ClinicalTrials.gov study NCT00479765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ImGTS for Patients With Cerebral Palsy and With Mobility Limitations (Phase 2)
ClinicalTrials.gov study NCT06100341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.